We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -5.71% | 1.65 | 1.60 | 1.70 | 1.90 | 1.625 | 1.75 | 15,893,319 | 11:54:33 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.32 | 12.79M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/5/2021 10:28 | Consistent 50K buys. Lots of single figure trades, really weird. What's going on? | frrinvest | |
13/5/2021 22:29 | There was also the 521k and 250k trades at 53p (I assume buys) from yesterday afternoon reported middayish. So MMs needed around 1m stock to cover those two and yours. Hopefully normal service resumes tomorrow. | donaferentes | |
13/5/2021 20:56 | Large late trade delayed from early-session, 370k shares and obviously a buy. Much of the rest of the day's selling must have been to fill that buy? | cyberbub | |
13/5/2021 16:51 | Can't see anything new that we don't know in the accounts. In itself reassuring and very detailed set out on all fronts. Rather pedestrian future outlook, sticking to facts of planned activities, minimal positive opinion expressed. But all us clearly in track with Accrufer launch in US and elsewhere, paediatric trials and research into PT20 phosphate combiner to be resumed. All looks good. Roll on Amat's update and June's launch in US. | donaferentes | |
13/5/2021 16:47 | Mid May US update? | powerp2 | |
13/5/2021 16:02 | Annual accounts RNS. | donaferentes | |
13/5/2021 11:05 | Looks encouraging Parob | cyberbub | |
13/5/2021 07:42 | Talent Acquisition Manager at IQVIA status update 2 days ago on LinkedIn:IQVIA is very excited about our partnership with Shield Therapeutics and together we are seeking Professional Sales Reps. For more info and to apply, please go to: https://jobs.iqvia.c | parob | |
12/5/2021 14:20 | What will really light up the share price is if they brought forward the launch date from end of June to beginning of June. This would make up for some of the lost time and give them more credibility and set them on a firm footing. However, even end of June/begin July launch date will be goodness. They have an announcement to make soon (mid May I hear - so Fri or Mon). All hands to the pump. The current valuation of c. £100m is very cheap. So if they get it right, multi-bagger in the making. | frrinvest | |
12/5/2021 08:24 | Bought in today | someuwin | |
11/5/2021 09:36 | Snap. Can also sell for above mid price....looking positive for an leg up. | dandu69 | |
11/5/2021 09:29 | No live quote for buying at present | 78steve | |
11/5/2021 08:40 | Great video and sets stall out well incl rewards but risks as well. IMHO makes a compelling play. | ttny2004 | |
11/5/2021 08:30 | Textbook break upwards from the flag with a bit of funky finance love helping the cause.US launch update expected this or next week. | parob | |
11/5/2021 08:23 | Well some PR from a yputuber is better than the BOD attempting anything such as PR | glasswala | |
11/5/2021 08:08 | Here's the funky finance vid for you. | thelongandtheshortandthetall | |
11/5/2021 07:57 | Thanks for bringing this to our attention, I`d never heard of him til now. Will keep an eye on his channel. | dandu69 | |
11/5/2021 07:11 | Funky Finance video now has over 2100 views. Certainly helps to bring the stock to more people's attention.Shares in LIT went up about 10% after his video was released on that stock.Should be a good day. | parob | |
10/5/2021 23:49 | Just thought I would post here to get post 2000 :-) Childish I know. | cyberbub | |
10/5/2021 21:24 | Pat viera and Mateus are the best | nico115 | |
10/5/2021 21:09 | Been looking at their patent expiry timeline. Looks like most aspects are covered until 2035 but the main one (P005) is about to expire, and if an extension is granted will only go a few more years. Anyone got any comments? It seems odd that they apparently did a deal with Vitra in 2010 but it's taken 11 years to commercialise Ferracru?My other niggle is the China deal. Is IP theft a concern?Comments from any long-termers would be appreciated. | cyberbub | |
10/5/2021 20:21 | Parob that's all very well, but there are 80% more shares in issue than last year.... So it's not like for like. Having said that, I agree it seems that the only key remaining risk here is execution risk. *If* management pull it off then we should be at multiples of 50p in time... GLA NAI | cyberbub | |
10/5/2021 19:35 | Mateus (Funky Finance) has just released a MUST WATCH video outlining the investment case here.His tweet:"This Stock is Down 70% from it's All Time High... Here's Why I'm Betting on a BIG Recovery!"Exciting timeline ahead for this company. If they execute, the upside is fantastic.Ft. a shoutout to Uncle Nick! @patviera ?hTTps://youtu.be/8Z | parob | |
10/5/2021 19:32 | Nice balanced view from Mateus of Funky Finance - don't be fooled by this guy's appearance - he's a clever cookie | walter walcarpets |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions